Asia Pacific Drug Delivery Across Blood Brain Barrier Market Size & Outlook
Related Markets
Asia Pacific drug delivery across blood brain barrier market highlights
- The Asia Pacific drug delivery across blood brain barrier market generated a revenue of USD 59.0 million in 2018.
- The market is expected to grow at a CAGR of 30.1% from 2019 to 2027.
- In terms of segment, increasing the permeability of bbb was the largest revenue generating drug delivery technology in 2018.
- Trojan Horse Approach is the most lucrative drug delivery technology segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2019 to 2027.
Asia Pacific data book summary
| Market revenue in 2018 | USD 59.0 million |
| Market revenue in 2027 | USD 631.6 million |
| Growth rate | 30.1% (CAGR from 2018 to 2027) |
| Largest segment | Increasing the permeability of bbb |
| Fastest growing segment | Trojan Horse Approach |
| Historical data covered | 2016 - 2017 |
| Base year for estimation | 2018 |
| Forecast period covered | 2019 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Other Non-Invasive BBB Technologies |
| Key market players worldwide | Roche, OSSIANIX, InSightec, AngioChem, Bioasis Technologies Inc, CarThera, JCR Pharmaceuticals Co Ltd, Brainsgate |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 10.1% of the global drug delivery across blood brain barrier market in 2018.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 631.6 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Delivery Across Blood Brain Barrier Market Scope
Drug Delivery Across Blood Brain Barrier Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Brainsgate | View profile | 11-50 | Caesarea, Hefa, Israel, Asia | http://www.brainsgate.com/ |
| CarThera | View profile | 1-10 | Paris, Ile-de-France, France, Europe | http://carthera.eu/ |
| OSSIANIX | View profile | 1-10 | Philadelphia, Pennsylvania, United States, North America | http://www.ossianix.com |
| Bioasis Technologies Inc | View profile | - | 157 Church Street, 19th Floor, New Haven, CT, United States, 06510 | https://www.bioasis.us |
| AngioChem | View profile | 11-50 | Montréal, Quebec, Canada, North America | http://www.angiochem.com |
| InSightec | View profile | 251-500 | Tirat Carmel, Hefa, Israel, Asia | http://www.insightec.com |
| JCR Pharmaceuticals Co Ltd | View profile | 932 | 3-19 Kasuga-cho, Ashiya, Hyogo, Japan, 659-0021 | http://www.jcrpharm.co.jp |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
Asia Pacific drug delivery across blood brain barrier market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug delivery across blood brain barrier market will help companies and investors design strategic landscapes.
Increasing the permeability of bbb was the largest segment with a revenue share of 36.44% in 2018. Horizon Databook has segmented the Asia Pacific drug delivery across blood brain barrier market based on trojan horse approach, bispecific antibody rmt approach, increasing the permeability of bbb, passive diffusion, other non-invasive bbb technologies covering the revenue growth of each sub-segment from 2016 to 2027.
- Asia Pacific Drug Delivery Across Blood Brain Barrier Drug Delivery Technology Outlook (Revenue, USD Million, 2016-2027)
- Increasing the Permeability of BBB
- Trojan Horse Approach
- Passive Diffusion
- Other Non-Invasive BBB Technologies
- Bispecific Antibody RMT Approach
- Asia Pacific Drug Delivery Across Blood Brain Barrier Application Outlook (Revenue, USD Million, 2016-2027)
- Alzheimer’s Disease
- Epilepsy
- Parkinson’s Disease
- Multiple Sclerosis
- Brain Cancer
- Hunter’s Syndrome
- Other Application
Reasons to subscribe to Asia Pacific drug delivery across blood brain barrier market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific drug delivery across blood brain barrier market databook
-
Our clientele includes a mix of drug delivery across blood brain barrier market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug delivery across blood brain barrier market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug delivery across blood brain barrier market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific drug delivery across blood brain barrier market size, by country, 2016-2027 (US$M)
Asia Pacific Drug Delivery Across Blood Brain Barrier Market Share, 2018 & 2027 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
